Overview

The Gene Technology Act 2000, enacted by the Commonwealth Parliament, aims to regulate the use, handling, and release of genetically modified organisms (GMOs) in Australia to protect human health and the environment. The Act establishes a comprehensive framework overseen by the Gene Technology Regulator, which is responsible for assessing applications and managing risks associated with gene technology. The policy objective of the Act is to ensure that any potential risks posed by GMOs are identified and managed appropriately, thereby safeguarding public health and the environment. In response to this framework, the Office of the Gene Technology Regulator has issued a consultation notice regarding a proposed field trial of genetically modified cotton by CSIRO. The trial, aimed at assessing the agronomic performance and fibre quality of the GM cotton under field conditions, has undergone a risk assessment which concludes that the proposed release poses negligible risk to human health and the environment. The Regulator is inviting written submissions to finalise the Risk Assessment and Risk Management Plan, which will inform the decision on whether to issue the licence for the trial.

Scope and Application

The Gene Technology Act 2000, as amended by the C2015G01004 legislation, governs the regulation of genetically modified organisms in Australia, with the intent to safeguard public health and the environment. This Act applies to entities and individuals involved in the development, handling, and release of genetically modified organisms, including the proposed field trial of genetically modified cotton by CSIRO. The geographic reach of this Act is national, as it pertains to activities across all states and territories of Australia. The application of the Act extends to all activities involving genetically modified organisms, including research, development, and commercial use, unless explicitly exempted or excluded by the legislation or subsequent subordinate instruments. The Act allows for the creation of specific regulations and guidelines through subordinate instruments to further define and manage the scope of its application. For instance, the current consultation on DIR 136 for the GM cotton field trial in Narrabri, New South Wales, exemplifies how the Act's application is extended and tailored through detailed licence conditions to mitigate identified risks. The exclusions under this Act primarily concern activities that do not involve gene technology or those that have been otherwise exempted under specific provisions of the Act or related regulations.

Key Provisions

The primary sections of this legislation (C2015G01004) pertain to the proposed field trial of genetically modified (GM) cotton, as detailed in the application DIR 136 submitted by CSIRO (section 1). These sections outline the specifics of the trial, including the location (Narrabri, New South Wales), the period (October 2015 to May 2018), and the maximum planting area (1 hectare per year) (section 2). Furthermore, it is explicitly stated that the GM cotton will not be used in human food or animal feed (section 3). The legislation imposes several obligations and requirements on the parties involved. The Gene Technology Regulator is tasked with assessing the licence application and preparing a Risk Assessment and Risk Management Plan (RARMP) to evaluate the potential risks to human health and the environment (section 4). The draft licence conditions proposed in the RARMP are designed to manage these risks by limiting the size, location, and duration of the release, as well as restricting the spread and persistence of the GMOs and the introduced genetic material (section 5). CSIRO, as the applicant, is required to adhere to these conditions if the licence is granted and to ensure that the trial is conducted in compliance with the regulatory framework (section 6). Failure to comply with the terms and conditions outlined in the legislation may result in various consequences. The specific offences, penalties, or civil/criminal consequences for breach are not detailed within the text of the legislation itself but would typically be outlined in the relevant sections of the Gene Technology Act 2000. These consequences could include fines, imprisonment, or other legal actions as stipulated by the applicable laws (section 7). The maximum penalties for breaches would be determined based on the specific nature of the offence and the relevant provisions of the Gene Technology Act 2000.